Screener
Novavax NVAX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income, net | 8,919 | 11,902 | 20,744 | 21,957 |
| Income (loss) before income tax expense | (51,676) | 107,454 | (60,182) | 627,300 |
| Income tax expense | 1,711 | 946 | 2,696 | 2,146 |
| Net income (loss) | $(53,387) | $106,508 | $(62,878) | $625,154 |
| Net income (loss) per share: | ||||
| Basic | $(0.32) | $0.66 | $(0.38) | $3.87 |
| Diluted | $(0.32) | $0.62 | $(0.38) | $3.55 |
| Weighted average number of common shares outstanding: |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's net income?
- Novavax (NVAX) reported net income of -$53.39M in Q2 2026.
- How has Novavax's net income changed year-over-year?
- Novavax's net income decreased by 150.1% year-over-year, from $106.51M to -$53.39M.
- What is the long-term trend for Novavax's net income?
- Over 4 years (2021 to 2025), Novavax's net income has grown at a -29.1% compound annual growth rate (CAGR), from -$1.74B to $440.3M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Novavax's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude